| Makale Türü |
|
||
| Dergi Adı | Rsc Advances (Q2) | ||
| Dergi ISSN | 2046-2069 Dergi Bilgileri (2026) | ||
| Dergi Tarandığı Indeksler | SCI-Expanded | ||
| Makale Dili | İngilizce | Basım Tarihi | 07-2026 |
| Cilt / Sayı / Sayfa | 16 / 34 / 33196–33212 | DOI | 10.1039/d6ra02731h |
| Makale Linki | https://doi.org/10.1039/d6ra02731h | ||
| UAK Araştırma Alanları |
Organik Kimya
|
||
| Özet |
| Lung cancer remains one of the leading causes of cancer-related mortality worldwide and necessitates the development of novel targeted agents. In this study, a series of new thiosemicarbazone derivatives (5a–r) were synthesized and evaluated for their anticancer potential through combined in vitro and in silico approaches. Cytotoxic activities were assessed against lung adenocarcinoma cells (A549) and normal bronchial epithelial cells (BEAS-2B). Among the tested compounds, 5p emerged as the most potent derivative, exhibiting an IC50 value of 3.41 µM against A549 cells, superior to sorafenib (IC50 = 4.02). Importantly, 5p demonstrated a remarkably high selectivity index (SI = 17.5), substantially exceeding that of sorafenib (SI = 5.5), indicating preferential cytotoxicity toward cancer cells. Apoptosis assays revealed that 5p significantly induced apoptotic cell death in A549 cells, supporting that its … |
| Anahtar Kelimeler |
| Atıf Sayıları | |
| Web of Science | 1 |
| Scopus | 1 |
| Google Scholar | 1 |
| Dergi Adı | RSC Advances |
| Kısa Adı | RSC ADV |
| Yayıncı | ROYAL SOC CHEMISTRY |
| Açık Erişim | Evet |
| ISSN | 2046-2069 |
| E-ISSN | 2046-2069 |
| Wos Quartile | Q2 |
| Scopus Quartile | Q1 |
| Tarandığı Indeksler | SCIE , Scopus |
| WoS Kategoriler | CHEMISTRY, MULTIDISCIPLINARY |
| Scopus Kategoriler | CHEMICAL ENGINEERING (MISCELLANEOUS) | CHEMISTRY (MISCELLANEOUS) |